SKLB-11A is a novel small-molecule compound identified as a selective activator of Sirtuin 3 (SIRT3), a key mitochondrial enzyme involved in cellular energy regulation and oxidative stress reduction. Preclinical studies show that SKLB-11A enhances mitochondrial protein deacetylation, improves ATP production, and protects cardiomyocytes under stress conditions. Its targeted mechanism makes it a promising candidate for […]
Author Archives: truemeds
Rediscovery of the Prodrug Strategy: Prodrugs are chemically modified therapeutics designed to improve drug properties such as solubility, bioavailability, and tissue selectivity. Traditionally applied to small molecules, the prodrug approach is now being extended to complex modalities like PROTACs, addressing their poor permeability and pharmacokinetics. This review outlines key prodrug strategies—enzyme activation, self-immolative linkers, redox/pH […]
Photosensitizers are light-sensitive compounds that play a critical role in technologies ranging from cancer therapy to solar energy. Upon light activation, they transfer energy to surrounding molecules, producing reactive oxygen species (ROS) that drive chemical or biological changes. This blog post explores how photosensitizers work, their chemical classes—such as porphyrins, phthalocyanines, and BODIPY dyes—and their […]
Relationship Between Gut Microbiota and Cancer. Since the beginning of the 21st century, significant breakthroughs have been made in cancer research, among which the association between gut microbiota and cancer has garnered increasing attention. A growing body of evidence suggests that gut microbiota can influence the host’s response to cancer therapy by modulating the immune […]
AMPK Activators: AMP-activated protein kinase (AMPK) serves as a central regulator of cellular energy homeostasis, coordinating metabolic pathways that balance ATP production and consumption. Recent research highlights the therapeutic potential of AMPK activators, ranging from clinically established drugs like metformin to natural polyphenols and novel synthetic molecules. These activators function through both indirect mechanisms, such […]
DNA Methylation Reimagined: DNA methylation has long been portrayed as a process of sweeping erasure and re-establishment across the genome. However, recent high-resolution studies reveal a more nuanced picture in which stability and change are carefully compartmentalized. CpG-island promoters, critical for gene regulation, remain largely unmethylated and protected, while repetitive elements and intergenic regions experience […]
Oveporexton (TAK-861) is a novel, oral orexin receptor 2 agonist developed by Takeda Pharmaceuticals for the treatment of Narcolepsy Type 1. Clinical trials have shown significant improvements in daytime alertness and sleep stability with a favorable safety profile. As it moves toward FDA and EMA approval in 2026, TAK-861 is expected to transform narcolepsy treatment […]
Berbamine dihydrochloride is a bisbenzylisoquinoline alkaloid derived from Berberis species, known for its wide-ranging pharmacological effects. Recent scientific studies have highlighted its potential as an antiviral, anticancer, and autophagy-modulating agent. It has demonstrated promising activity against RNA viruses like SARS-CoV-2 and Mayaro virus, and shown the ability to inhibit tumor growth by targeting critical signaling […]
Bacterial Conversations: are no longer viewed as solitary organisms but as highly social communities that rely on chemical communication systems called quorum sensing. Through the release and detection of signaling molecules, microbes can coordinate group behaviors such as bioluminescence, biofilm formation, virulence expression, and competence. These microbial “languages” range from species-specific signals to universal molecules […]
Degrader-Antibody Conjugates (DACs) are a cutting-edge class of therapeutics that merge the selectivity of monoclonal antibodies with the catalytic efficiency of targeted protein degraders, such as PROTACs and molecular glues. This blog post explores the foundational principles, mechanism of action, therapeutic applications, development challenges, and future market outlook of DACs in modern drug discovery. As […]